Immunologic adjuvant
US4301152A · kind A · utility
8Cited by
3References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 26, 1979 |
| Grant date | Nov 17, 1981 |
| Priority date | — |
| Expiry date | Oct 26, 1999 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J43/003
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Immunologic adjuvants are obtained by the synthesis of 6-(5-cholesten-3.beta.-yloxy)hexyl 6-amino-6-deoxy-1-thio-.beta.-D-galactopyranoside and its 6-deoxy-6-oleamido derivative.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.